where is retatrutide approved for weight loss: Study shows 30% body weight loss Retatrutide for Weight Loss: TRIUMPH-1

doi: 10.1210/jc.2012-3855 62 SukumaranV.TsuchimochiH.SonobeT.ShiraiM.PearsonJ

Addressing obesity directly can normalize blood pressure without pharmaceutical intervention in many cases, though Retatrutide appears to provide additional blood pressure lowering effects beyond what weight loss alone would predict

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone

A new study found GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer